amoxapine
Amoxapine first received marketing approval in the United States in 1992. It is used in the treatment of major depressive disorder. Reference standards of Amoxapine API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => N-2-Chlorobenz-[b,f][1,4]oxazepine-11-yl Amoxapine
[catalogue_number] => PA 28 72520
[category_ids] => ,70,71,75,78,82,
[chemical_name] =>
[weight] => 541.43
[form] => C30H22Cl2N4O2
[cas] => 1216608-66-0
[pslug] => 1216608-66-0-n-2-chlorobenz-b-f-1-4-oxazepine-11-yl-amoxapine-pa2872520
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
N-2-Chlorobenz-[b,f][1,4]oxazepine-11-yl Amoxapine
Catalogue No.:PA 28 72520
Molecular Formula : C30H22Cl2N4O2
Molecular Weight : 541.43